Search
Descriptor English: Dihydroergotamine
Descriptor Spanish: Dihidroergotamina
Descriptor Portuguese: Di-Hidroergotamina
Descriptor French: Dihydroergotamine
Entry term(s): Agit
Angionorm
Clavigrenin
D Tamin Retard L.U.T.
D-Tamin Retard L.U.T.
D.H.E. 45
DET MS
DHE 45
DHE Puren
DHE Ratiopharm
DHE-45
DHE-Puren
DHE-Ratiopharm
DHE45
Dihydergot
Dihydroergotamin AL
Dihydroergotamine Mesylate
Dihydroergotamine Methanesulfonate
Dihydroergotamine Sandoz
Dihydroergotamine-Sandoz
Dihytamin
Erganton
Ergomimet
Ergont
Ergotam Von Ct
Ikaran
Mesylate, Dihydroergotamine
Methanesulfonate, Dihydroergotamine
Migranal
Orstanorm
Seglor
Tamik
Verladyn
Von Ct, Ergotam
Tree number(s): D03.132.327.412.225
D03.633.400.562.300
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D004087
Scope note: A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Vasoconstrictor Agents
Dopamine Agonists
Analgesics, Non-Narcotic
Registry Number: 436O5HM03C
CAS Type 1 Name: Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-
Previous Indexing: Ergotamine (1966-1974)
Public MeSH Note: 78; was see under ERGOTAMINE 1963-77
Online Note: search ERGOTAMINE 1966-74
History Note: 78(75); was see under ERGOTAMINE 1963-77
DeCS ID: 4127
Unique ID: D004087
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1978/01/01
Date of Entry: 1999/01/01
Revision Date: 2017/05/24
Dihydroergotamine - Preferred
Concept UI M0006401
Scope note A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.
Preferred term Dihydroergotamine
Clavigrenin - Narrower
Concept UI M0485096
Preferred term Clavigrenin
D-Tamin Retard L.U.T. - Narrower
Concept UI M0485095
Preferred term D-Tamin Retard L.U.T.
Entry term(s) D Tamin Retard L.U.T.
DET MS - Narrower
Concept UI M0485094
Preferred term DET MS
DHE-45 - Narrower
Concept UI M0352821
Preferred term DHE-45
Entry term(s) D.H.E. 45
DHE 45
DHE45
DHE-Puren - Narrower
Concept UI M0485093
Preferred term DHE-Puren
Entry term(s) DHE Puren
DHE-Ratiopharm - Narrower
Concept UI M0485099
Preferred term DHE-Ratiopharm
Entry term(s) DHE Ratiopharm
Dihydroergotamin AL - Narrower
Concept UI M0485109
Preferred term Dihydroergotamin AL
Dihydroergotamine Mesylate - Narrower
Concept UI M0330548
Preferred term Dihydroergotamine Mesylate
Entry term(s) Dihydroergotamine Methanesulfonate
Mesylate, Dihydroergotamine
Methanesulfonate, Dihydroergotamine
Dihytamin - Narrower
Concept UI M0485107
Preferred term Dihytamin
Erganton - Narrower
Concept UI M0485106
Preferred term Erganton
Ergomimet - Narrower
Concept UI M0354246
Preferred term Ergomimet
Ergont - Narrower
Concept UI M0485105
Preferred term Ergont
Ergotam Von Ct - Narrower
Concept UI M0485104
Preferred term Ergotam Von Ct
Entry term(s) Von Ct, Ergotam
Ikaran - Narrower
Concept UI M0485103
Preferred term Ikaran
Migranal - Narrower
Concept UI M0006402
Preferred term Migranal
Entry term(s) Dihydergot
Dihydroergotamine Sandoz
Dihydroergotamine-Sandoz
Orstanorm - Narrower
Concept UI M0354247
Preferred term Orstanorm
Seglor - Narrower
Concept UI M0006400
Preferred term Seglor
Entry term(s) Agit
Tamik - Narrower
Concept UI M0485102
Preferred term Tamik
Verladyn - Narrower
Concept UI M0485101
Preferred term Verladyn
Angionorm - Narrower
Concept UI M0485097
Preferred term Angionorm



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey